MARKETING PROBLEMS OF SMALL SCALE INDIGENOUS PHARMACEUTICAL MANUFACTURING COMPANIES IN NIGERIA TABLE OF CONTENT Title page Certification Dedication Acknowledgement Abstract Table of content CHAPTER ONE 0. INTRODUCTION OF “MARKETING PROBLEMS OF SMALL SCALE INDIGENOUS PHARMACEUTICAL MANUFACTURING COMPANIES IN NIGERIA 1. Background of the Study 2. Statement of the problem 3. Objective of the Study 4. Research Hypothesis 5. Scope of the Study 6. Significance of the Study
Free E-mail E-mail address Telephone
Generoso Pharmaceuticals & Chemicals Inc. Case 1 Generoso Pharmaceuticals & Chemicals‚ Inc. Statement of the Problem To determine the possible exercises the Generoso Pharmaceuticals & Chemicals‚ Inc. should take in order to bear in competition and where to find superfluous capital. Areas of Consideration (SWOT ANALYSIS) Strengths * Liquidity of the Company * Ready for expansion * A wide supply for desolate materials * Conservative cash management policies Opportunities
Premium Investment Economics
Pharmaceutical Companies and Ethics It would be a mistake to claim that the pharmaceutical industry has not contributed to a better way of life and a better standard of living. They have come up with treatments for cancer-in some types of cancer they have even come up with the cure. It would also be naïve however to pretend that there are not some issues that have come up throughout the years that lead us to question whether the pharmaceutical industry’s main concern is the well being of the patients
Premium Clinical trial Pharmacology Pharmaceutical industry
SYNTHESIS OF THE PHARMACEUTICAL ASPIRIN (ACETYLSALICYLIC ACID) AIM: The aim for this experiment was to synthesise a small amount of aspirin with salicylic acid as the starting product and sulphuric acid as the catalyst. The product obtained from this reaction will be impure and will need to be purified. This will be done by recrystallization. We will then record the products’ melting point and calculate the yield in order to determine the degree of purity of the aspirin sample. Diagrammatic scheme
Premium Acetic acid Aspirin Acetic anhydride
Risinger David.Risinger@morganstanley.com +1 (1)212 761 6494 Thomas Chiu Thomas.Chiu@morganstanley.com +1 (1)212 761 3688 Dana Yi Industry View In-Line October 18‚ 2010 Dana.Yi@morganstanley.com +1 (1)212 761 8713 Large Cap & Specialty Pharmaceuticals Christopher Caponetti Christopher.Caponetti@morganstanley.com +1 (1)212 761 6235 Pharma trends in pictures In this note‚ we include macro trend analysis plus therapeutic category and product-specific charts. Macro pages to start; then company
Premium Morgan Stanley
The burden of the responsible falls onto to ZAP Pharmaceutical Company since both contact: Written and oral are bindings. According to Section 2-209 of the Uniform Commercial Code it seeks to protect and make effective all necessary and desirable modifications of sales contracts without regards to the technicalities which[at common law] hamper such adjustment. Subsection (1) permits all modifications‚ written and oral‚ to be binding without consideration. Subsection (2) allows the parties to exclude
Premium Law Contract Contractual term
The global pharmaceutical industry 1. Identify the main environmental forces currently affecting the global pharmaceutical industry. The PESTEL analysis can be used to identify the main environmental forces for the industry: Political • Stringent government regulation and powerful purchaser pressures. • Governments around the world focused on pharmaceuticals as a politically easy target in efforts to control rising healthcare expenditure. • Inter-country pricing disparities. Economic
Premium Pharmaceutical industry Generic drug Food and Drug Administration
Ethics in the Pharmaceutical Industry The pharmaceutical industry started in the middle Ages‚ 18th AD in Baghdad in 754 by an Arabian. Until the early 70’s the industry grew at a small pace. In the 1970’s business began to boom and competition began to upsurge. In the 1990’s these industries and companies became more aggressive with their marketing strategies. In ’97 the U.S. Food and Drug Administration brought new rules and regulations concerning the marketing area and it required companies to
Premium Pharmacology Marketing Sales
Ethics in pharmaceutical marketing xxxxx EMBA 1.1/Academic Skills Subject Outline December 23rd‚ 2012 Prof. xxxxx Ethics and pharmaceutical marketing The pharmaceutical industry has been facing challenges with respect to ethical marketing and promotional practices. The conflict of commercial interests with adherence to ethical practices has been a subject of much deliberation. While such debates tend to have a high degree of subjective and emotive content‚ it is also a concern
Premium Marketing Corporate social responsibility Business ethics
ASSIGNMENT PHARMACEUTICAL INDUSTRY SUBMITTED TO: PROF. JEEMOL UNNI SUBMITTED BY: PUNEET JAIN (33101) Market Failure The involvement of government in the pharmaceutical sector has been to a much greater extent when compared to other sectors. We have studied that in the scenario of “Perfect Markets” where consumers and sellers are left to their own to carry out business activities lead to an optimal solution. However it’s a bit different in case of pharmaceutical sector‚ because if pharmaceutical companies
Premium Pharmacology Pharmaceutical industry Clinical trial